Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.
about
Personalized management of cirrhosis by non-invasive tests of liver fibrosis.Non-invasive prediction of forthcoming cirrhosis-related complications.Role of spleen elastography in patients with chronic liver diseasesLiver ultrasound elastography: More than staging the disease.Non-invasive assessment of liver fibrosis in chronic hepatitis B.Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.The diagnostic value of the FIB-4 index for staging hepatitis B-related fibrosis: a meta-analysis.Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study.Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B?Virus and Host Testing to Manage Chronic Hepatitis B.Risk prediction of hepatitis B virus-related hepatocellular carcinoma in the era of antiviral therapy.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Comparison of diagnostic accuracy of aspartate aminotransferase to platelet ratio index and fibrosis-4 index for detecting liver fibrosis in adult patients with chronic hepatitis B virus infection: a systemic review and meta-analysis.Prediction of long-term clinical outcome in a diverse chronic hepatitis B population: Role of the PAGE-B score.Critical comparison of elastography methods to assess chronic liver disease.Prognostic durability of liver fibrosis tests and improvement in predictive performance for mortality by combining tests.Measuring spleen stiffness to predict varices in chronic hepatitis B cirrhotic patients with or without receiving non-selective beta-blockers.Liver stiffness measurement reliability and main determinants of point shear-wave elastography in patients with chronic liver disease.Hepatitis B cure: From discovery to regulatory approval.Probability-based interpretation of liver stiffness measurement in untreated chronic hepatitis B patients.Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C.Commentary: prognostication of chronic hepatitis B--are Fibrotest and Fibroscan the final answers?Clinical Application of Vibration Controlled Transient Elastography in Patients with Chronic Hepatitis B.Body-mass index is associated with fibrosis regression during long-term nucleoside analogue therapy in chronic hepatitis B.Baseline and serial liver stiffness measurement in prediction of portal hypertension progression for patients with compensated cirrhosis.Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.Quantitative Elastography Methods in Liver Disease: Current Evidence and Future Directions.Noninvasive assessments of liver fibrosis with transient elastography and Hui index predict survival in patients with chronic hepatitis B.
P2860
Q26777483-65BE9DD7-A7E9-4BC1-8EA5-59AB45D26042Q27000645-BAC5E208-D2EF-429D-8C83-CA7DCD3E254EQ28072862-E20EAD95-824B-43D6-8775-DDBE960D37B4Q30407629-D1DBDE0D-7519-40FF-AC59-C97DD4BCEAEDQ30427489-BCD7B7E3-1E8A-42EB-91A2-FB5C2ADAA431Q33787655-262A62B7-E0F1-4427-B3EB-A8FB91F26CDFQ34105030-E6AB05C4-0918-43F7-B2E4-8621C6D251F4Q34450720-E26F5DEC-6463-4718-B5D9-B0252FF7F968Q35594244-AB909D2F-F8A9-4B9F-A791-4E6E229D96CCQ36958940-3E08D966-F9D6-418E-9A08-6511CD5E6CEDQ37241565-7A7B8D3B-C224-445B-80C7-97795D8F1F80Q38188809-07351E00-EF15-46E9-B8A5-B4AB767337ECQ38240784-713C4D2C-CA52-4C67-BB64-EF44078DE5A7Q38763937-A075D9FF-880D-4E93-B6A5-4C7057858968Q38858344-526F61E5-17CF-4DB2-B641-6A5B05D0D947Q40451725-C56C6EE4-3D73-486F-8BCD-27958CE1456EQ40537499-5477A506-0F58-4C14-B65D-6C2EFA8E28C1Q40673321-64D29678-88F5-487A-BDB8-214D3B1F7D3DQ41952398-4109D876-522C-483D-8D73-0613531A4412Q42175529-1B16F5D9-61A1-4761-A246-3E31C233EEB7Q42237621-867317BA-280D-4157-8811-6A4FC52E9580Q42263805-EBA94D43-D73E-4877-90BE-058040A3FFF3Q47101834-C17A0FFA-BA79-430D-B994-9EE684A48EB6Q48339011-BA62BBAC-1370-4F0A-B5A0-6113748118A0Q51102598-F157460C-E35B-4647-B4A1-B7C3E7915E11Q51139539-EC8D7948-3F9B-4B60-BD89-6791DB71F621Q52692830-75E7D7CF-4ABD-4C31-8E0C-3FDF20A39BC9Q54319962-3757F3F1-66D0-4DEE-96C7-6A31F81AB461
P2860
Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@en
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@nl
type
label
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@en
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@nl
prefLabel
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@en
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@nl
P2093
P2860
P356
P1476
Non-invasive tests for fibrosi ...... fected with hepatitis B virus.
@en
P2093
J Vergniol
P-H Bernard
V de Lédinghen
W Merrouche
P2860
P304
P356
10.1111/APT.12307
P407
P577
2013-04-05T00:00:00Z